Cover Picture: Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6‐Oxopurine Phosphoribosyltransferases (ChemMedChem 10/2015). Issue 10 (October 2015)
- Record Type:
- Journal Article
- Title:
- Cover Picture: Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6‐Oxopurine Phosphoribosyltransferases (ChemMedChem 10/2015). Issue 10 (October 2015)
- Main Title:
- Cover Picture: Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6‐Oxopurine Phosphoribosyltransferases (ChemMedChem 10/2015)
- Authors:
- Kaiser, Martin M.
Hocková, Dana
Wang, Tzu‐Hsuan
Dračínský, Martin
Poštová‐Slavětínská, Lenka
Procházková, Eliška
Edstein, Michael D.
Chavchich, Marina
Keough, Dianne T.
Guddat, Luke W.
Janeba, Zlatko - Abstract:
- <abstract abstract-type="graphical" xml:lang="en"> <title> <x xml:space="preserve">Abstract</x> </title> <p> <bold>The front cover picture shows</bold> the crystal structure of the active site of human hypoxanthine–guanine phosphoribosyltransferase (HGPRT) in complex with (<italic>S</italic>)‐3‐hydroxy‐2‐(phosphonoethoxy)propylguanine (HPEPG). HPEPG exhibits high potency for the hypoxanthine‐guanine‐xanthine phosphoribosyltransferase (HGXPRT) of <italic>Plasmodium falciparum</italic> (<italic>K</italic><sub>i</sub> = 0.1 μ<sc>M</sc>), as well as for human HGPRT (<italic>K</italic><sub>i</sub> = 0.6 μ<sc>M</sc>). The crystal structures of acyclic nucleoside phosphonates (ANPs), including HPEPG, in complex with human HGPRT reveal the binding mode of novel inhibitors and show specific interactions with active site residues. Such information is important for future design of more potent inhibitors of plasmodial 6‐oxopurine phosphoribosyltransferases. This approach may represent a viable strategy to treat malaria. More details can be found in the Full Paper by Luke W. Guddat, Zlatko Janeba et al. on <bold>page 1707 in Issue 10, 2015</bold>. (DOI: <ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1002/cmdc.201500322</ext-link>).<graphic position="anchor" mimetype="image" xlink:href="ark:/27927/pgj2xmrbc0c" orientation="portrait" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink" /></p> </abstract>
- Is Part Of:
- ChemMedChem. Volume 10:Issue 10(2015:Oct.)
- Journal:
- ChemMedChem
- Issue:
- Volume 10:Issue 10(2015:Oct.)
- Issue Display:
- Volume 10, Issue 10 (2015)
- Year:
- 2015
- Volume:
- 10
- Issue:
- 10
- Issue Sort Value:
- 2015-0010-0010-0000
- Page Start:
- 1589
- Page End:
- 1589
- Publication Date:
- 2015-10
- Subjects:
- Pharmaceutical chemistry -- Periodicals
615.19005 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1860-7187 ↗
http://www3.interscience.wiley.com/cgi-bin/jhome/110485305 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/cmdc.201500388 ↗
- Languages:
- English
- ISSNs:
- 1860-7179
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3172.254000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 3078.xml